Melanoma Diagnostics and Therapeutics Market Growth During Forecast Period 2016-2022

Click here to view original web page at news.watercloudsolutions.com

As per Melanoma Research Foundation, melanoma is usually (but not always) a cancer of the skin. It is defined as a cancer that occurs in melanocytes – cells that make the melanin pigment. CM, MM and OM are the major categories of melanoma. According to the American Skin Association, there has been an increased incidence of melanoma worldwide. The median age of diagnosis of melanoma is 59 years and the median age of death due to it is 67 years.

Market Dynamics
Due to an increase in the prevalence of melanoma across regions and improvement in the healthcare facilities, there is an increased growth of the melanoma diagnostics and therapeutics market. The various driving and restraining factors of the market are as stated below:
Drivers:
Increase in melanoma cases
Approval and uptake of premium-priced products
Effective immunotherapies
Label extension of current therapies into the new settings
Government initiatives
Technological advancements

“The Final Report will cover the impact analysis of COVID-19 on this industry.”

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10065016

Restraints:
Lack of awareness in some developing regions
High cost associated with the therapy
Economic crisis
Regulatory issues

The Global Melanoma Diagnostics and Therapeutics Market is expected to grow at a CAGR of more than 15% over the forecasted period.
Market Segmentation
Segmentation based on cancer type:
Superficial
Nodular
Lentigo Maligna
Acral Lentiginous
Amelanotic Melanoma

Segmentation based on cancer stage:
Stage 0
Stage I
Stage II
Stage III
Stage IV

Segmentation based on diagnosis:
Dermatoscopy
Sentinel lymph node biopsy
X-rays
Blood tests
Ultrasound

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10065016

Segmentation based on treatments:
Treatment for early stage (Excision and Mohs Surgery)
Treatment for advanced stage (Chemotherapy, Biological therapy, Targeted therapy, Radiotherapy, Immune therapy, lymphadenectomy)
Segmentation based on geography:
North America
Europe
Asia-Pacific
Opportunities

Owing to its large population and higher prevalence of melanoma and its treatment rates, USA has the largest market size. The melanoma diagnostics and therapeutics market is dominated by North America. Also, Europe shows great potential for higher market expansion due to the treatment rates and infiltration of the premium drugs into the market. However, countries in the Asia-Pacific region such as Japan, China and India are expected to be the fastest growing markets for melanoma diagnostics and therapeutics.

Key Players
BMS
Merck
Roche
Other Prominent Vendors are:
AB Science
Amgen
Bayer
Celgene
Daiichi Sankyo
Eisai
Galectin Therapeutics
GSK
Novartis
Pfizer
Vical
ZIOPHARM

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609